of public perceptions of FDA regulation. He holds a B.Sc. (honors) in computer science and psychology from the University of Witwatersrand, Johannesburg, South Africa, and a doctorate in clinical psychology from Rutgers University.

Michele Bloch, M.D., Ph.D., is the acting chief of the NCI’s Tobacco Control Research Branch. Dr. Bloch has served as a program director in the research areas of women and tobacco, tobacco industry documents, international tobacco control and prevention, and other areas. She oversaw the successful implementation of the NCI’s Tobacco Industry Document Research Program Announcement and played a key role in developing and implementing NIH’s first research initiative devoted to international tobacco research and capacity building. Dr. Bloch’s research activities have included working with the National Institute of Child Health and Human Development’s Global Network for Women’s and Children’s Health Research to survey pregnant women’s knowledge, attitudes, and behaviors regarding tobacco use and secondhand smoke exposure in nine low- and middle-income nations. Dr. Bloch has helped to organize numerous scientific meetings, including the 2008 Expert Meeting on Tobacco Exposure During Pregnancy in Low- and Middle-Income Countries: Establishing Research Priorities; the 2006 NIH State of the Science Conference on Tobacco Use; the 2005–2006 meetings of the President’s Cancer Panel; and the 2004 NCI Women, Tobacco, and Cancer Working Group meeting. She also helped to develop and implement the NCI’s Smokefree Meetings Policy. She is the author of numerous publications for scientific and lay audiences. Dr. Bloch received her bachelor of science degree in biochemistry from Cornell University and received her doctor of medicine and doctor of philosophy degrees in pharmacology from the Washington University School of Medicine, where she also completed a residency in anatomic pathology.

Otis Webb Brawley, M.D., FACP, is the chief medical and scientific officer and executive vice president of the American Cancer Society (ACS), where he is responsible for promoting the goals of cancer prevention, early detection, and high-quality treatment through cancer research and education. He champions efforts to decrease smoking, improve diet, detect cancer at the earliest stage, and provide the critical support that cancer patients need. He guides efforts to enhance and focus the research program, upgrade ACS’s advocacy capacity, and concentrate community cancer control efforts in



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement